Global Viral Conjunctivitis Drugs Market to grow at a CAGR of 2.41% during the period 2016 - 2020; Finds New Report

Report forecast the global viral conjunctivitis drugs market to grow at a CAGR of 2.41% during the period 2016-2020.

Viral conjunctivitis, or pink eye, is a type of infectious conjunctivitis that is commonly caused by an adenovirus. Herpes simplex virus (HSV), picornavirus (enterovirus 70, Coxsackie A24), varicella-zoster virus, poxvirus (molluscum contagiosum and vaccinia), and human immunodeficiency virus (HIV) are some of the other viruses that are responsible for the infection. Discomfort through watery discharge is the main symptom of this highly contagious condition.

It is often associated with keratoconjunctivitis, which results in slightly blurred vision. No specific treatment option is available for the infection, which heals by itself in 2-3 weeks. Antibiotics and anti-inflammatory drugs are used only if the condition persists. In certain instances, when the infection is serious or persists for weeks, topical antiviral drugs are used. Corneal lesions persist for months even after the condition heals.

The report covers the present scenario and the growth prospects of the global viral conjunctivitis drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used for the treatment and prevention of viral conjunctivitis.

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

According to the report, awareness programs and campaigns by organizations in public and private sectors to help individuals understand how to treat and control the spread of the viral conjunctivitis infection will result in more people opting for treatment.

Further, the report states that the diagnosis rates of viral conjunctivitis are observed to be low, as most people prefer to allow the condition to heal on its own. Misdiagnosis also leads to the low diagnosis rate.

Global Viral Conjunctivitis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the Global Viral Conjunctivitis Drugs Market: Akorn, Alcon, Allergan, and Bausch & Lomb.

Other Prominent Vendors in the market are: Adenovir Pharma, Marinomed Biotechnologie, Mediolanum Laboratoires, NanoViricides, Nicox, Novartis, Panoptes Pharma, Rapid Pathogen Screening, Shire, Starpharma, and Valeant Pharmaceuticals.

Market driver

• Rising awareness
• For a full, detailed list, view our report

Market challenge

• Low diagnosis rate
• For a full, detailed list, view our report

Market trend

• Use of off-label drugs
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 53 pages and 29 Exhibit “Global Viral Conjunctivitis Drugs Market 2016 - 2020” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market Overview, Market Landscape, Disease overview, Pipeline analysis, Market segmentation by route of administration, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://mrr.cm/J3v

Related Report;

Global Myocardial Infarction Drugs Market 2016-2020 - Visit at - http://mrr.cm/JUZ

Global Peptide Therapeutics Market 2016-2020 - Visit at - http://mrr.cm/JU4